BIOMAT Database Logo BIOMAT Database Logo

Bosentan improves systemic sclerosis-related peripheral circulation insufficiency. 2011

Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010147 Pain Measurement Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies. Analgesia Tests,Analogue Pain Scale,Formalin Test,McGill Pain Questionnaire,Nociception Tests,Pain Assessment,Pain Intensity,Pain Severity,Tourniquet Pain Test,Visual Analogue Pain Scale,Analog Pain Scale,Assessment, Pain,McGill Pain Scale,Visual Analog Pain Scale,Analgesia Test,Analog Pain Scales,Analogue Pain Scales,Formalin Tests,Intensity, Pain,Measurement, Pain,Nociception Test,Pain Assessments,Pain Intensities,Pain Measurements,Pain Questionnaire, McGill,Pain Scale, Analog,Pain Scale, Analogue,Pain Scale, McGill,Pain Severities,Pain Test, Tourniquet,Questionnaire, McGill Pain,Scale, Analog Pain,Scale, Analogue Pain,Scale, McGill Pain,Severity, Pain,Test, Analgesia,Test, Formalin,Test, Nociception,Test, Tourniquet Pain,Tests, Nociception,Tourniquet Pain Tests
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D001775 Blood Circulation The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM. Blood Flow,Circulation, Blood,Blood Flows,Flow, Blood
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077300 Bosentan A sulfonamide and pyrimidine derivative that acts as a dual endothelin receptor antagonist used to manage PULMONARY HYPERTENSION and SYSTEMIC SCLEROSIS. 4-t-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide,Bosentan Anhydrous,Bosentan Monohydrate,Ro 47-0203,Ro-47-0203,Tracleer,Ro 47 0203,Ro 470203
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata
Successful treatment with bosentan for pulmonary hypertension and reduced peripheral circulation in juvenile systemic sclerosis.
October 2011, Pediatric cardiology,
Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata
Bosentan in systemic sclerosis.
June 2008, Drugs of today (Barcelona, Spain : 1998),
Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata
Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.
May 2012, The Australasian journal of dermatology,
Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata
Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
December 2010, The Journal of rheumatology,
Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata
Bosentan fosters microvascular de-remodelling in systemic sclerosis.
December 2012, Clinical rheumatology,
Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata
Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis.
May 2014, The Journal of rheumatology,
Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata
Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease.
September 2006, European journal of clinical investigation,
Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata
Effect of ambrisentan on peripheral circulation in patients with systemic sclerosis.
January 2016, Modern rheumatology,
Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata
Bosentan for digital ulcers in patients with systemic sclerosis.
January 2012, The Journal of dermatology,
Shusuke Yagi, and Masashi Akaike, and Ken-ichi Aihara, and Takashi Iwase, and Yuka Sumitomo-Ueda, and Sumiko Yoshida, and Toshio Matsumoto, and Masataka Sata
[Acute insufficiency of the peripheral circulation].
January 1973, Medicinski pregled,
Copied contents to your clipboard!